Found 0 matching trials
A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma PHASE1 This study is a multicenter, open-label study of polatuzumab vedotin admini...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
CPX-351 Therapy for MDS After Hypomethylating Agent Failure PHASE2 The purpose of this study is to evaluate the efficacy of treatment with CPX...
Show More Location
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
Learn More & Join Trial
Abraxane and Alimta in Advanced Solid Tumors PHASE1 RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilize...
Show More Location
University of California Davis Cancer Center
Learn More & Join Trial
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer PHASE2 The trial consists of a series of parallel multi-centre single arm phase II...
Show More Location
Aberdeen Royal Infirmary
Learn More & Join Trial
A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL) PHASE2 The purpose of this study is to compare the pharmacokinetics (PK) of both l...
Show More Location
Regional Children Clinical Hospital
Learn More & Join Trial
Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer PHASE2 This phase II trial studies the safety and effectiveness of an induction ch...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis PHASE1 The purpose of this study is assess safety, safest dose, and effectiveness ...
Show More Status
Active Not Recruiting
Location
Boston Medical Center
Learn More & Join Trial
Clofarabine in High Risk Myelodysplastic Syndrome (MDS) PHASE1 This study aims to determine the maximal tolerated dose (MTD) and dose limi...
Show More Learn More & Join Trial
Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer PHASE3 This is a phase-3, open-label, multicenter, two-arm treatment study to eval...
Show More Location
Multiple Locations
Learn More & Join Trial
To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with AD PHASE3 A multicenter, randomized, double-blind, vehicle-controlled, parallel group...
Show More Location
Beijing Children's Hospital, Capital Medical University
Learn More & Join Trial